The most effective treatments for eczema accomplish three things: They calm inflammation, bring relief from itch and restore ...

Sanofi stock plummeted Thursday after the company's experimental eczema drug proved meaningfully inferior to Dupixent.

Amlitelimab showed efficacy in skin clearance and disease severity compared to placebo in a phase 3 study with adolescent and ...

Eczema, or atopic dermatitis, often worsens during seasonal changes like monsoon and autumn. Fluctuating humidity, allergens, and infections can trigger flare-ups.

World Atopic Eczema Day 2025 calls for early intervention, better care and greater awareness of the hidden toll of atopic ...

Data from the late-stage trial of amlitelimab weren’t as strong as the results seen in Phase 2, adding to doubts about a drug ...

Sanofi (SNY) stock drops after Phase 3 trial results for amlitelimab, its experimental therapy for eczema, disappointed ...

Sanofi (NASDAQ:SNY) stock took a beating Thursday after its latest eczema drug trial left Wall Street unconvinced, even ...

World Atopic Eczema Day 2025 calls for early intervention, better care, and greater awareness of the hidden toll of atopic ...

Apollo Therapeutics’ $15 million bet on Avalo’s anti-IL-18 monoclonal antibody appears to have paid off after the candidate ...

Doctors have shared their top tips for travelling with eczema, offering some wise words for people who find heading to ...

Eczema affects 1 in 5 infants and can lead to allergies and asthma later. Dr. Elisa Song, chief medical officer at Tiny Health, explains study on how parents can help prevent baby eczema.